Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics
American Journal of Respiratory Cell and Molecular Biology · 2023
DOI: 10.1165/rcmb.2021-0508oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2023. Verfasst von Amelia E Freeman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics. Hauptthemen laut MEDLINE: Hyperoxia, Lung Injury, Bronchopulmonary Dysplasia, Pneumonia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is a common lung disease of premature infants. Hyperoxia exposure and microbial dysbiosis are contributors to BPD development. However, the mechanisms linking pulmonary microbial dysbiosis to worsening lung injury are unknown. Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that regulates oxidative stress responses and modulates hyperoxia-induced lung injury. We hypothesized that airway dysbiosis would attenuate Nrf2-dependent antioxidant function, resulting in a more severe phenotype of BPD. Here, we show that preterm infants with a Gammaproteobacteria-predominant dysbiosis have increased endotoxin in tracheal aspirates, and mice monocolonized with the representative Gammaproteobacteria Escherichia coli show increased tissue damage compared with germ-free (GF) control mice. Furthermore, we show Nrf2-deficient mice have worse lung structure and function after exposure to hyperoxia when the airway microbiome is augmented with E. coli. To confirm the disease-initiating potential of airway dysbiosis, we developed a novel humanized mouse model by colonizing GF mice with tracheal aspirates from human infants with or without severe BPD, producing gnotobiotic mice with BPD-associated and non–BPD-associated lung microbiomes. After hyperoxia exposure, BPD-associated mice demonstrated a more severe BPD phenotype and increased expression of Nrf2-regulated genes, compared with GF and non–BPD-associated mice. Furthermore, augmenting Nrf2-mediated antioxidant activity by supporting colonization with Lactobacillus species improved dysbiotic-augmented lung injury. Our results demonstrate that a lack of protective pulmonary microbiome signature attenuates an Nrf2-mediated antioxidant response, which is augmented by a respiratory probiotic blend. We anticipate antioxidant pathways will be major targets of future microbiome-based therapeutics for respiratory disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics.
- Heersink School of Medicine, and.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama; and.
- Section of Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.
ORCID-Profile: Charitharth V Lal
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Freeman, A. E., Willis, K. A., Qiao, L., Abdelgawad, A. S., Halloran, B., Rezonzew, G., Nizami, Z., Wenger, N., Gaggar, A., Ambalavanan, N., Tipple, T. E., & Lal, C. V. (2023). Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2021-0508oc
Vancouver
Freeman AE, Willis KA, Qiao L, Abdelgawad AS, Halloran B, Rezonzew G, et al. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics. American Journal of Respiratory Cell and Molecular Biology. 2023. doi:10.1165/rcmb.2021-0508oc
BibTeX
@article{Freeman2023,
author = {Freeman, Amelia E and Willis, Kent A and Qiao, Luhua and Abdelgawad, Ahmed S and Halloran, Brian and Rezonzew, Gabriel and Nizami, Zoha and Wenger, Nancy and Gaggar, Amit and Ambalavanan, Namasivayam and Tipple, Trent E and Lal, Charitharth V},
title = {Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2023},
doi = {10.1165/rcmb.2021-0508oc}
}
EUVIMED